Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-006782
Filing Date
2022-06-17
Accepted
2022-06-17 19:25:38
Documents
1
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 form4-06172022_040626.html 4  
1 form4-06172022_040626.xml 4 4271
  Complete submission text file 0001415889-22-006782.txt   5812
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 415-801-8100
Graham G. Walmsley (Reporting) CIK: 0001777517 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39712 | Film No.: 221025567